Crown Bioscience B.V.
Crown Bioscience Netherlands B.V. (CBNL, formerly OcellO) is a fast-growing innovative CRO offering unique 3D cell culture-based services that accelerate pre-clinical drug discovery and development. CBNL’s best-in-class technology meets a growing need to reduce drug development costs. CBNL has sites in Leiden and Utrecht and is a part of Crown Bioscience Inc. CBNL shows strong year-on-year growth and now provides services for many of the leading global pharmaceutical companies. The company has an active R&D program to maintain its leading position as a provider of advanced tissue-based assays.
